Clinical Research Directory
Browse clinical research sites, groups, and studies.
Real World Study of Oral Upadacitinib Tablets to Assess Adverse Events and Change in Disease Activity in Adolescent and Adult Chinese Participants With Atopic Dermatitis
Sponsor: AbbVie
Summary
Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. This study will assess how safe and effective upadacitinib is in treating AD in adolescent and adult Chinese participants. Upadacitinib is an approved drug for treating AD. Approximately 200 adolescent and adult participants who are prescribed upadacitinib by their physician in accordance with local label will be enrolled in China. Participants will receive upadacitinib as prescribed by their physician according to their routine clinical practice and local label. Participants will be followed up for approximately 24 months per participant and 30 days after last treatment dose for safety data collection. There is expected to be no additional burden for participants in this trial. Participants will attend regular visits during the study at a hospital or clinic according to their routine clinical practice
Official title: A Prospective, Multi-center, Post-marketing, Observational Study to Evaluate the Safety and Effectiveness of Upadacitinib in Chinese Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (AD)
Key Details
Gender
All
Age Range
12 Years - Any
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2023-08-18
Completion Date
2026-06
Last Updated
2025-07-16
Healthy Volunteers
No
Conditions
Locations (18)
Peking University Third Hospital /ID# 257722
Beijing, Beijing Municipality, China
The First Affiliated Hospital Of Fujian Medical University /ID# 257725
Fuzhou, Fujian, China
Dermatology Hospital of Southern Medical University /ID# 261862
Guangzhou, Guangdong, China
The Eighth Affiliated Hospital, Sun Yat-sen universtiy /ID# 257737
Shenzhen, Guangdong, China
People's Hospital of Henan Province /ID# 257736
Zhengzhou, Henan, China
Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 257724
Wuhan, Hubei, China
The First Hospital of China Medical University /ID# 257641
Shenyang, Liaoning, China
Second Affiliated Hospital of Xian Jiaotong University /ID# 257733
Xi'an, Shaanxi, China
Shandong Dermatological Hospital /ID# 257727
Jinan, Shandong, China
Huashan Hospital, Fudan University /ID# 256456
Shanghai, Shanghai Municipality, China
Ruijin Hospital, Shanghai Jiaotong University School of Medicine /ID# 257726
Shanghai, Shanghai Municipality, China
Shanghai Skin Disease Hospital /ID# 257719
Shanghai, Shanghai Municipality, China
Chengdu Second Municipal People's Hospital /ID# 257732
Chengdu, Sichuan, China
West China Hospital, Sichuan University /ID# 257720
Chengdu, Sichuan, China
Sichuan Provincial People's Hospital /ID# 263898
Chengdu, Sichuan, China
Hangzhou First People's Hospital /ID# 261867
Hangzhou, Zhejiang, China
The second affiliated hospital of Zhejiang University school of medicine /ID# 257723
Hangzhou, Zhejiang, China
Ningbo First Hospital /ID# 263884
Ningbo, Zhejiang, China